Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818584 · ClinicalTrials.gov registry record · Phase 1
An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates
A Phase 1 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00818584 is a Phase 1 study that has completed, run by Astellas Pharma. The registered enrollment target is 13 participants.
The verdict
NCT00818584, a Phase 1 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will evaluate pharmacokinetics and safety of intravenous micafungin in neonates with suspected candida infection
Interventions
- DRUG Micafungin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-08 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00818584
The ClinicalTrials.gov registry entry for NCT00818584 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Micafungin is the first listed.
NCT00818584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00818584 about?
NCT00818584 is a clinical study titled "An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates". This study will evaluate pharmacokinetics and safety of intravenous micafungin in neonates with suspected candida infection
What is the current status of trial NCT00818584?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2007-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00818584?
The interventions under investigation include: Micafungin (DRUG).
Who is sponsoring clinical trial NCT00818584?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.